CompendiumTRA full manuscript

TRA — Supplementary Material

Source: TRA_Revised_Supplementary_Material.docx. Companion material; verify exact correspondence to manuscript version before publication.

Supplementary Material

Temporal Response Architecture (TRA)

Supplementary Methods

Literature identification was domain-driven. Publications were retained when they contributed either direct procedural evidence or mechanistically relevant information to at least one predefined response domain of the Temporal Response Architecture.

Inclusion did not require agreement with the proposed model. Discordant observations were retained when relevant to a predefined domain. Publications describing ocular complications arising through mechanisms outside the predefined pigment-associated anterior-segment and aqueous-outflow scope were not incorporated into the mechanistic architecture but were used to define its boundaries.

Review articles were used primarily for background, terminology, and citation chaining rather than as primary evidence for mechanistic conclusions.

The literature was synthesized within predefined response domains using a focused mechanistic approach. This strategy links direct procedural findings to experimental insights concerning trabecular function, aqueous dynamics, and cellular processing.

Supplementary Table S1. PubMed Search Strategy for the Focused Mechanistic Review

Database: PubMed. Coverage: database inception through 30 September 2026.

Search A — Direct iris-directed laser evidence

("laser iris depigmentation"[Title/Abstract] OR "iris depigmentation"[Title/Abstract] OR "cosmetic iridoplasty"[Title/Abstract] OR "iris color change"[Title/Abstract] OR "iris colour change"[Title/Abstract] OR "iris pigment modification"[Title/Abstract] OR "iris pigmentation"[Title/Abstract]) AND (laser*[Title/Abstract] OR Nd:YAG[Title/Abstract] OR "selective laser trabeculoplasty"[Title/Abstract] OR SLT[Title/Abstract])

Purpose: To identify human clinical reports and direct preclinical studies involving intentional laser modification of iris pigmentation.

Search B — Pigment–trabecular and aqueous-outflow interaction

(pigment*[Title/Abstract] OR "pigment dispersion"[Title/Abstract] OR "pigmentary glaucoma"[Title/Abstract]) AND ("trabecular meshwork"[Title/Abstract] OR "aqueous outflow"[Title/Abstract] OR "outflow facility"[Title/Abstract]) AND (phagocyt*[Title/Abstract] OR migration[Title/Abstract] OR contract*[Title/Abstract] OR cytoskeleton[Title/Abstract] OR "intraocular pressure"[Title/Abstract])

Purpose: To identify evidence concerning the effects of pigment exposure on trabecular cellular behavior and conventional aqueous outflow.

Search C — Laser-associated inflammatory and remodeling responses

("selective laser trabeculoplasty"[Title/Abstract] OR "laser trabeculoplasty"[Title/Abstract] OR SLT[Title/Abstract]) AND (inflammation[Title/Abstract] OR inflammatory[Title/Abstract] OR cytokine*[Title/Abstract] OR "interleukin-1"[Title/Abstract] OR "IL-1"[Title/Abstract] OR "tumor necrosis factor"[Title/Abstract] OR TNF[Title/Abstract] OR "anterior chamber"[Title/Abstract])

Purpose: To identify mechanistically relevant inflammatory, cellular, and matrix-remodeling responses following anterior-segment laser exposure.

Search D — Cellular processing, macrophages, and clearance

("trabecular meshwork"[Title/Abstract] OR "aqueous outflow"[Title/Abstract]) AND (macrophage*[Title/Abstract] OR monocyte*[Title/Abstract] OR phagocyt*[Title/Abstract] OR clearance[Title/Abstract] OR debris[Title/Abstract]) AND (laser[Title/Abstract] OR pigment*[Title/Abstract] OR iridotomy[Title/Abstract])

Purpose: To identify mechanistic evidence concerning particulate processing, phagocytosis, monocyte/macrophage recruitment, and recovery of conventional aqueous outflow.

Supplementary identification: Reference lists of eligible primary studies and relevant reviews were manually screened for additional publications addressing the predefined response domains.

Interpretive note: These searches were intended to support focused mechanistic synthesis and should not be interpreted as a comprehensive systematic search of all literature concerning cosmetic eye-color modification.

Supplementary Table S2. Study-Level Evidence Map and Interpretive Boundaries

Evidence-category definitions: Category A, direct human procedural evidence; Category B, direct preclinical iris evidence; Category C, mechanistically analogous evidence; Category D, integrative inference generated by the present synthesis. Categories reflect biological proximity to the clinical question rather than methodological quality.

Supplementary Table S3. Contextual, Scope-Boundary, and Related Conceptual Literature

Contextual note: L-SAFE, L-OAT, and TRA address complementary dimensions of anterior-segment assessment, phenotyping, and temporal response.

Supplementary table 1 (source order)

StudyModel and exposureObservation informing TRAResponse domainClass
Yildirim et al., 2016Rabbit iris; Frequency-doubled Nd:YAG iris exposurePigment reduction with transient AC cells/flare and no significant IOP change in the reported protocolTarget interaction; inflammatory responseB
Basoglu & Celik, 2018Human; sectoral heterochromia; 532-nm SLT-platform iris treatmentHuman iris-directed treatment using a gradual zonal/staged approachTarget interactionA
Grimaldos Ruiz, 2021Human; 1176 eyes; Protocol-specific 532-nm Q-switched Nd:YAGCosmetic pigment change; reported longitudinal IOP behavior and inflammatory findings in a subsetTarget interaction; IOP responseA
Ning et al., 2022Human case; Cosmetic iris-lightening laserSecondary pigment dispersion following treatmentPigment redistributionA
Ong et al., 2023Human case; Cosmetic iris laserRefractory secondary pigmentary glaucomaPigment redistribution; IOP responseA
Swampillai et al., 2023Human case; Cosmetic iris color-change laserSecondary pigmentary glaucomaPigment redistribution; IOP responseA
Liu et al., 2023Human case; Multiple cosmetic iris-laser sessionsSevere bilateral IOP elevation with dense pigmented AC findingsPigment redistribution; IOP responseA
Jaber et al., 2026Human cases; Procedures described as LIDMarked IOP elevation following cosmetic iris laser treatmentIOP responseA
Matsumoto & Johnson, 1997Human trabecular tissue; Phagocytic assessmentActive phagocytic capacity of trabecular meshwork cellsTrabecular biologyC
Epstein et al., 1986Living monkey model; Experimental pigment infusionAcute reduction in outflow facility followed by recovery and particulate uptakeOutflow disturbance; recoveryC
Dang et al., 2018Experimental pigmentary-glaucoma model; Pigment exposureIOP elevation preceding later reduction in trabecular phagocytic activityOutflow response; temporal relationshipC
Wang et al., 2019Trabecular-meshwork cellular model; Pigment exposureReduced migration and phagocytosis with cytoskeletal and contractile changesPigment–trabecular interactionC
De Keyser et al., 2017Human SLT; Selective laser trabeculoplastyEarly anterior-chamber cellular response and transient IOP changesInflammatory responseC
Bradley et al., 2000Laser-trabeculoplasty model; Laser exposureEarly IL-1β/TNF-α signaling and matrix-remodeling responsesInflammatory signalingC
Alvarado et al., 2010SLT-related experimental/human outflow work; Selective laser trabeculoplastyMonocyte/macrophage recruitment and modulation of conventional outflowCellular processing; recoveryC
Nemoto et al., 2023Mouse laser-iridotomy model and TM cells; Laser iridotomyPigment/debris accumulation, phagocytic processing, and association between clearance and IOP recoveryCellular processing; recoveryC

Supplementary table 2 (source order)

SourceLiterature categoryContribution to TRA context
Imesch et al., 1997Background biologyIris morphology and pigmentation
Sturm & Larsson, 2009Background biologyIris pigmentation and phenotype
D’Oria et al., 2022Contextual reviewBackground on eye-color modification techniques; citation chaining
D’Oria & Alio, 2025Contextual reviewUpdated procedural context and citation chaining
Ferrari, 2021Scope boundaryDemonstrates reported structural iris injury
Flores-Márquez et al., 2023Scope boundaryDemonstrates posterior-segment laser-associated injury
Wisdorf et al., 2025Scope boundaryDemonstrates lamellar macular-hole/epiretinal changes
Mete, L-SAFE, 2026Related conceptual frameworkClinical state and safety-oriented trajectory interpretation
Mete, L-OAT, 2026Related conceptual frameworkMultimodal measurement and iris phenotyping

Return to TRA manuscript